Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

China Pharma Holdings (CPHI) Times Interest Earned (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Times Interest Earned for 16 consecutive years, with -$91.9 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Times Interest Earned rose 42.05% year-over-year to -$91.9, compared with a TTM value of $42.2 through Sep 2025, up 149.26%, and an annual FY2024 reading of -$167.76, down 566.35% over the prior year.
  • Times Interest Earned was -$91.9 for Q3 2025 at China Pharma Holdings, up from -$96.31 in the prior quarter.
  • Across five years, Times Interest Earned topped out at $81.85 in Q4 2023 and bottomed at -$222.37 in Q2 2021.
  • Average Times Interest Earned over 5 years is -$62.96, with a median of -$11.75 recorded in 2021.
  • The sharpest move saw Times Interest Earned soared 459.78% in 2023, then tumbled 6026.77% in 2024.
  • Year by year, Times Interest Earned stood at $4.08 in 2021, then surged by 257.98% to $14.62 in 2022, then surged by 459.78% to $81.85 in 2023, then plummeted by 84.94% to $12.32 in 2024, then tumbled by 845.76% to -$91.9 in 2025.
  • Business Quant data shows Times Interest Earned for CPHI at -$91.9 in Q3 2025, -$96.31 in Q2 2025, and -$111.78 in Q1 2025.